Zylox-Tonbridge said its board proposed amendments to its articles of association that would cancel the company’s Supervisory Committee. The company said the Supervisory Committee’s powers would be exercised by the board’s Audit Committee if the amendments take effect. The proposed changes will be put to shareholders for approval by special resolution at the 2025 annual general meeting. Zylox-Tonbridge said the Supervisory Committee will continue to perform its duties until the amendments are approved and become effective.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260317-12056280), on March 17, 2026, and is solely responsible for the information contained therein.